Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 1
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (494)
- Volume 17, 2023 (15)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 1, 2007

Role of basiliximab in the prevention of acute cellular rejection in adult to adult living-related liver transplantation: a single center experience || FREE PAPER ||
S Gruttadauria, L Mandalà , D Biondo, M Spampinato, V Lamonaca, et al
Biologics: Targets and Therapy 2007, 1:69-73
Published Date: 15 August 2007

Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease
Arpad Z Barabas, Chad D Cole, Arpad D Barabas, Rene Lafreniere
Biologics: Targets and Therapy 2007, 1:59-68
Published Date: 15 August 2007

Potential of adult neural stem cells for cellular therapy
Philippe Taupin
Biologics: Targets and Therapy 2007, 1:53-58
Published Date: 15 August 2007

Treatment of ankylosing spondylitis: focus on etanercept
Tracy Frech
Biologics: Targets and Therapy 2007, 1:45-51
Published Date: 15 August 2007

Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)
Joseph M Geskey, Neal J Thomas, Gretchen L Brummel
Biologics: Targets and Therapy 2007, 1:33-43
Published Date: 15 August 2007

Trastuzumab in the management of early and advanced stage breast cancer
Rupert Bartsch, Catharina Wenzel, Guenther G Steger
Biologics: Targets and Therapy 2007, 1:19-31
Published Date: 15 August 2007

Biological markers in the etiology of psoriasis: Targeted treatment options
Catia de Felice, Georgiana Clare Marulli, Marco Ardigò, Enzo Berardesca
Biologics: Targets and Therapy 2007, 1:11-18
Published Date: 15 August 2007

First line targeted therapies in breast cancer: focus on bevacizumab || FREE PAPER ||
Amalia Milano, Gugliemo Nasti, Rosario Vincenzo Iaffaioli, Francesco Caponigro
Biologics: Targets and Therapy 2007, 1:3-10
Published Date: 15 August 2007

Editorial || FREE PAPER ||
Sanjay Awasthi
Biologics: Targets and Therapy 2007, 1:1-2
Published Date: 15 August 2007